2023 - Research.com Medicine in France Leader Award
The scientist’s investigation covers issues in Internal medicine, Immunology, Lymphoma, Gastroenterology and Surgery. His Internal medicine research focuses on Oncology and how it relates to Clinical trial and Malignancy. His Lymphoma study integrates concerns from other disciplines, such as Virus, Hepatitis C virus, Lymphatic system and Zidovudine.
His Gastroenterology research incorporates themes from Survival rate, Regimen, Lymphoproliferative disorders and Clinical significance. His research investigates the connection between Surgery and topics such as Cohort that intersect with issues in Cohort study. His biological study spans a wide range of topics, including Cancer research and Chemotherapy.
Olivier Hermine focuses on Internal medicine, Immunology, Lymphoma, Oncology and Cancer research. Olivier Hermine combines subjects such as Gastroenterology and Surgery with his study of Internal medicine. His Immunology study frequently draws connections between adjacent fields such as Disease.
To a larger extent, Olivier Hermine studies Pathology with the aim of understanding Lymphoma. His study in Oncology is interdisciplinary in nature, drawing from both Clinical trial and Chemotherapy. The various areas that Olivier Hermine examines in his Leukemia study include Arsenic trioxide and Alpha interferon.
His main research concerns Internal medicine, Cancer research, Lymphoma, Oncology and Immunology. His Internal medicine study often links to related topics such as Gastroenterology. The concepts of his Cancer research study are interwoven with issues in Cancer and Leukemia.
The Lymphoproliferative disorders research Olivier Hermine does as part of his general Lymphoma study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science. His studies deal with areas such as Cytarabine, Chemotherapy, Hematopoietic stem cell transplantation and Lenalidomide as well as Oncology. His Immunology research is multidisciplinary, incorporating perspectives in Pathophysiology and In vivo.
Olivier Hermine spends much of his time researching Internal medicine, Lymphoma, Cancer research, Oncology and Immunology. Internal medicine connects with themes related to Gastroenterology in his study. Olivier Hermine has included themes like Immunohistochemistry, Virus, Inflammatory bowel disease and Chlorambucil in his Lymphoma study.
His Cancer research research incorporates elements of Leukemia, Serotonin pathway, Cell growth and Kynurenine. His work in Oncology covers topics such as Mantle cell lymphoma which are related to areas like Hematology. His Immunology research is multidisciplinary, incorporating elements of In vivo and Histamine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie;Nicole Brousse;Anne Marie Bouvier;Jean Frédéric Colombel.
The Lancet (2009)
Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection
Olivier Hermine;François Lefrère;Jean-Pierre Bronowicki;Xavier Mariette.
The New England Journal of Medicine (2002)
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.
P. Valent;C. Akin;L. Escribano;M. Födinger.
European Journal of Clinical Investigation (2007)
Transforming Growth Factor β1, in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Interleukin 4, Induces Differentiation of Human Peripheral Blood Monocytes into Dendritic Langerhans Cells
Frederic Geissmann;Catherine Prost;Jean-Paul Monnet;Michel Dy.
Journal of Experimental Medicine (1998)
Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)
O Hermine;C Haioun;E Lepage;MF d'Agay.
Treatment of Older Patients with Mantle-Cell Lymphoma
H. C. Kluin-Nelemans;Eva Hoster;Olivier Hermine;J. Walewski.
The New England Journal of Medicine (2012)
CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans
Sandra Weller;Ahmad Faili;Corinne Garcia;Moritz C. Braun.
Proceedings of the National Academy of Sciences of the United States of America (2001)
Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting
Kunihiro Tsukasaki;Olivier Hermine;Ali Bazarbachi;Lee Ratner.
Journal of Clinical Oncology (2009)
Caspase Activation Is Required for Terminal Erythroid Differentiation
Yael Zermati;Carmen Garrido;Sophie Amsellem;Serge Fishelson.
Journal of Experimental Medicine (2001)
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.
Olivier Hermine;Olivier Hermine;Xavier Mariette;Pierre-Louis Tharaux;Matthieu Resche-Rigon.
JAMA Internal Medicine (2021)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: